Cornu P, Speck B, Gratwohl A, Nissen C, Sartorius J, Jeannet M
Schweiz Med Wochenschr. 1979 Sep 29;109(37):1384-5.
18 patients with severe aplastic anemia (SAA) but without an HLA-identical sibling were treated by antilymphocyte globulin (ALG) followed by infusion of marrow cells from a semi-compatible family donor. 13 of these received low dose androgens after ALG: 11 (85%) achieved stable remission without transfusion requirement. One patient relapsed after 4 months, one patient with only partial remission died from infection. None of the 4 patients who did not receive androgens after ALG achieved remission. ALG, marrow and low-dose androgens represent a promising therapy for SAA and can be favorably compared with allogeneic bone marrow transplantation.
18例严重再生障碍性贫血(SAA)患者,无人类白细胞抗原(HLA)完全相同的同胞供者,接受抗淋巴细胞球蛋白(ALG)治疗,随后输注来自半相合家庭供者的骨髓细胞。其中13例在接受ALG治疗后接受了小剂量雄激素治疗:11例(85%)实现了无需输血的稳定缓解。1例患者在4个月后复发,1例仅部分缓解的患者死于感染。4例在接受ALG治疗后未接受雄激素治疗的患者均未实现缓解。ALG、骨髓和小剂量雄激素是治疗SAA的一种有前景的疗法,与异基因骨髓移植相比具有优势。